Pharmacoeconomics-Open
Scope & Guideline
Transforming Healthcare Through Collaborative Scholarship
Introduction
Aims and Scopes
- Cost-Effectiveness Analysis (CEA):
The journal publishes extensive research on cost-effectiveness analyses of various healthcare interventions, including pharmaceuticals, medical devices, and treatment protocols, providing a comprehensive understanding of their economic value. - Health Technology Assessment (HTA):
Pharmacoeconomics-Open focuses on health technology assessments that evaluate the clinical efficacy, safety, and economic implications of new treatments and technologies, guiding stakeholders in healthcare decision-making. - Budget Impact Analysis (BIA):
The journal includes studies on budget impact analyses, evaluating the financial implications of adopting new therapies or technologies within specific healthcare systems, aiding in resource allocation and policy planning. - Patient-Centered Outcomes:
Research highlighting patient-reported outcomes and quality of life assessments is central to the journal's scope, emphasizing the importance of patient perspectives in evaluating healthcare interventions. - Methodological Innovations in Economic Evaluation:
Pharmacoeconomics-Open encourages submissions that explore new methodologies in economic evaluation, including modeling techniques and statistical approaches, to enhance the rigor and applicability of pharmacoeconomic studies.
Trending and Emerging
- Integration of Artificial Intelligence (AI):
Recent publications emphasize the role of AI in automating health economic modeling and decision-making processes, showcasing innovative applications that enhance efficiency and accuracy in economic evaluations. - Real-World Evidence (RWE):
There is a growing trend towards incorporating real-world evidence in economic evaluations, with studies focusing on the effectiveness and cost implications of interventions in routine clinical practice, rather than controlled trial settings. - Value-Based Healthcare Models:
Emerging research emphasizes value-based healthcare approaches that assess treatments based on their outcomes relative to costs, reflecting a shift in focus from volume-based care to value-driven systems. - Patient-Centered and Multi-Criteria Decision Analysis:
An increasing number of studies are employing multi-criteria decision analysis (MCDA) frameworks that incorporate diverse stakeholder preferences, including patient values, in the evaluation of healthcare interventions. - Global Health Economics:
The journal is seeing a rise in submissions addressing global health economics, particularly in low- and middle-income countries, highlighting unique challenges and opportunities in these contexts.
Declining or Waning
- Traditional Cost-Utility Analysis:
There is a noticeable decline in the frequency of traditional cost-utility analyses focusing solely on generic health states, as researchers increasingly adopt more nuanced approaches that incorporate broader patient-reported outcomes. - Single-Condition Focused Studies:
Research solely centered on specific diseases or conditions, such as individual cancers or chronic illnesses, is becoming less prevalent, with a shift towards studies that consider broader healthcare systems and multiple conditions. - Static Economic Models:
The use of static economic models that do not account for real-world variability and long-term outcomes is decreasing, as there is a growing preference for dynamic modeling approaches that reflect changing patient populations and treatment landscapes.
Similar Journals
Journal of Health Economics and Outcomes Research
Pioneering studies that shape the future of public health.Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.
MDM Policy & Practice
Empowering Change in Health Systems GloballyMDM Policy & Practice is a premier open-access journal published by SAGE Publications Inc, focusing on the critical fields of Health Policy and Public Health, Environmental and Occupational Health. Since its inception in 2016, this journal has aimed to provide an authoritative platform for disseminating research findings, policy discussions, and innovative practices that drive improvements in health systems globally. With an impact factor that reflects its growing influence in the academic landscape, it holds a Q2 ranking in both Health Policy and Public Health categories as of 2023. This journal leverages its accessibility to foster a collaborative environment for researchers, policymakers, and practitioners alike, encouraging the exchange of ideas and knowledge to address pressing health challenges. Operating under a commitment to open access, MDM Policy & Practice ensures that vital research is available to a wider audience, fostering informed decision-making and progressive advancements in the health policy sphere.
VALUE IN HEALTH
Innovative Research Shaping Tomorrow's Health PoliciesVALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.
HEALTH ECONOMICS
Connecting theory and practice in health economics.HEALTH ECONOMICS is a premier academic journal published by Wiley, dedicated to advancing the field of health economics. With an ISSN of 1057-9230, this journal has been a vital resource since its inception in 1992, and continues to contribute significantly to the academic landscape as it extends its cover to 2024. With a distinguished ranking of Q1 in Health Policy for 2023, it showcases cutting-edge research and theoretical advancements that inform health policy and economic decision-making globally. The journal features rigorous peer-reviewed articles that address a diverse range of topics within health economics, making it an essential platform for researchers, financial analysts, policymakers, and students alike. Although not an Open Access journal, it strives to ensure accessibility of critical insights for a broad audience, further enhancing its influence within the health economics community.
Applied Health Economics and Health Policy
Empowering decision-makers with applied health economics.Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.
CLINICAL THERAPEUTICS
Empowering clinicians with evidence-based therapeutic advancements.Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.
ADVANCES IN THERAPY
Advancing therapeutic knowledge for a healthier tomorrow.ADVANCES IN THERAPY is a prestigious peer-reviewed journal published by SPRINGER, specializing in the diverse fields of medicine and pharmacology. Established in 1984, this influential journal has become an essential resource for researchers and professionals, boasting a commendable impact factor and categorically ranking within the Q1 quartile in both Medicine (Miscellaneous) and Medical Pharmacology as of 2023. With an impressive Scopus ranking at #52 out of 272 in the realm of medical pharmacology, it places itself in the top 81st percentile, underscoring its importance in advancing therapeutic knowledge and practices. Although the journal is not open access, it provides invaluable insights and the latest research findings in therapies that significantly impact patient care, making it a vital reference for clinicians, academicians, and students alike.
Health Services Management Research
Driving Evidence-Based Solutions in Health ManagementHealth Services Management Research is a premier academic journal published by SAGE PUBLICATIONS LTD, focusing on critical areas within the health policy domain. With an ISSN of 0951-4848 and E-ISSN 1758-1044, this UK-based journal has been a valuable resource for over three decades, converging from 1988 to 2024. Recognized for its contribution to the field, it holds a commendable Q2 quartile ranking, positioning it in the top 35% of journals in Health Policy, reflecting its significant impact within the academic community, as evidenced by its rank of 109 out of 310 in Scopus rankings, placing it in the 65th percentile. The journal aims to foster innovative research that addresses the complexities of health services management, making it an indispensable resource for researchers, professionals, and students dedicated to improving health systems. Although it currently does not offer Open Access, the journal remains committed to advancing knowledge and practice in health policy management through rigorous peer-reviewed articles, case studies, and evidence-based analyses.
Farmeconomia-Health Economics and Therapeutic Pathways
Exploring the economic dimensions of health policy and practice.Farmeconomia-Health Economics and Therapeutic Pathways is a pioneering journal within the field of health economics, dedicated to exploring the intersections of health policy, therapeutics, and economic evaluations. Published by SEED MEDICAL PUBLISHERS, this Open Access journal has been at the forefront of advancing knowledge since 2012, ensuring that vital research is readily accessible to a global audience without subscription barriers. The journal aims to facilitate the dissemination of insightful studies, systematic reviews, and theoretical discussions that determine the cost-effectiveness of therapeutic options, ultimately guiding evidence-based healthcare decisions. Based in *Torino, Italy*, this journal is committed to serving researchers, healthcare professionals, and students who are eager to contribute to and stay updated on the latest developments in health economics and policy implementation. With its broad-ranging scope and dedication to quality research, Farmeconomia stands as an essential resource for anyone engaged in the complex dynamics of health systems and their economic implications.
REVUE ECONOMIQUE
Illuminating Economic Discourse Since 1974REVUE ECONOMIQUE, published by PRESSES FOND NAT SCI POLIT in France, is a distinguished academic journal with an ISSN of 0035-2764 and an E-ISSN of 1950-6694. Established in 1974, the journal has evolved significantly over the years, focusing on a diverse range of topics within the field of economics, econometrics, and finance. With its commitment to presenting in-depth research and innovative perspectives, REVUE ECONOMIQUE serves as a vital resource for scholars, professionals, and students seeking to enhance their understanding of economic theories and practices. Although it is currently categorized in the Q4 quartile, ranking 241 out of 288 in the field, the journal aims to foster new dialogues and disseminate valuable insights that contribute to the economic discourse. The journal is not available as open access, but its rich repository of articles continues to attract readers interested in the complexities of economic dynamics. For more information, you can refer to their address at 27 RUE SAINT-GUILLAUME, 75341 PARIS 07, FRANCE.